Leaderboard

En | De
No articles selected!     View Cart  
You are here: Urology-Nephrology » Neoplasia/BPH 05. August 2026
Search
medline.ch
Neoplasia/BPH
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Inflammation-Infection
Nephrolithiasis
Renal Failure
Sexuality
Neoplasia/BPH
Others
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 9513  Previews Next
   
   Articles 1 - 20 / 190246  
   
Case Report: Diagnosis and treatment report and literature review of 2 cases of VHL-deficient renal cell carcinoma.
Front Oncol
Wang Y, Gao T, Ren N, Liu Y, Li Q, Guo X.
PMID: 42553075 [PubMed]


Diet and Physical Activity as Mediators of Weight Loss in a Digital Prostate Cancer Survivorship Intervention for Men: Secondary Analysis of the PC-PEP Randomized Trial.
Am J Mens Health
Power B, Smith NK, Ilie G, Rendon RA, Mason R, Kokorovic A, MacDonald C, Patil N, Bowes D, Bailly G, Wilke D, Langley E, Rutledge R.
PMID: 42552876 [PubMed - indexed for MEDLINE]


Frailty and Social Isolation of Elderly Prostate Cancer Patients: A Chain Mediating and Network Analysis of Illness Perception and Acceptance.
Nurs Open
Liu Y, Shen C, Huang Y, Jin Y, Zhang X, Wang H, Zhou J, Yao X, Li H, Chen W.
PMID: 42552627 [PubMed - indexed for MEDLINE]


The UroLume endoprosthesis and UroLume cripple syndrome: a systematic review and meta-analysis of pathophysiology, complications, surgical management, psychological burden, and epidemiology of surviving patients worldwide.
World J Urol
Kapos IP.
PMID: 42552506 [PubMed - indexed for MEDLINE]


Risk-Adapted Use of Adjuvant Systemic Therapy After Nephrectomy for Renal Cell Carcinoma: A Population-Based Study in the Post-approval Era.
Ann Surg Oncol
Filzmayer M, Petix M, Quarta L, Orlandi F, Goyal JA, Carmignani L, Briganti A, Micali S, Shariat SF, Wenzel M, Heß-Busch Y, Humke C, Saad F, Chun FK, Karakiewicz PI.
PMID: 42552493 [PubMed - as supplied by publisher]


PSMA PET in Prostate Cancer: Clinical Value, Access Challenges, and Priorities for Implementation.
Eur Urol Oncol
Peyrottes A, Turpin L, Hernández LF, Rivas JG, Rouprêt M.
PMID: 42552166 [PubMed - as supplied by publisher]


Re: Emanuele Messina, Antonella Borrelli, Alessandro Sciarra, et al. Primary Noncontrast Magnetic Resonance Imaging for Prostate Cancer Screening: A Randomized Clinical Trial (PROSA). Eur Urol 2025;89:246-57.
Eur Urol
Luca S, Ferrando L, Porpiglia F.
PMID: 42552153 [PubMed - as supplied by publisher]


Beyond the Trial: Can Audit and Feedback Produce Lasting Improvements in Transurethral Resection of Bladder Tumor Quality?
Fr J Urol
Mercier J, de la Taille A, Vordos D, Duquesne I.
PMID: 42551555 [PubMed - as supplied by publisher]


Mortality in Medicare-aged Men with Metastatic Prostate Cancer After the Introduction of Androgen Receptor Pathway Inhibitors: A Population-Based Study.
Urology
Kim IE Jr, Hartman R, Gandhi K, Nikita N, Banks J, Kelly WK, Keith SW, Kim IY, Lu-Yao G.
PMID: 42551541 [PubMed - as supplied by publisher]


Urinary incontinence after treatment for localized prostate cancer: A systematic review and meta-analysis.
Actas Urol Esp (Engl Ed)
Amaris Vanegas AP, Cabrera Díaz DC, Salgar Prada JD, Sánchez Moreno JV, Gómez Rodríguez DP.
PMID: 42551523 [PubMed - as supplied by publisher]


Imaging modalities in advanced prostate cancer: interim analysis of the Spanish cohort of the RING registry.
Actas Urol Esp (Engl Ed)
Chernysheva D, Gómez Gómez E, Burgos Revilla J, Fernández Conejo G, García Barreras S, Linares Espinós E, Gómez Villanueva A, Domínguez Esteban M, Mera Errasti A, Breda A, Fanti S, Bjartell A, Padhani AR, Sanguedolce F.
PMID: 42551522 [PubMed - as supplied by publisher]


Effectiveness and Safety of Hormonal Doublet Therapy in Metastatic Hormone-Sensitive Prostate Cancer: A Multicenter Real-World Study.
Actas Urol Esp (Engl Ed)
Guedes Oliva P, Pérez-Fentes D, De Pablos-Rodríguez P, Bardella-Altarriba C, Díaz-Pedrouzo A, Abuin-García J, Vera-Ballesteros FJ, Abella-Serra A, Ribera-Díaz D, Martínez-Corral ME, Gómez-Ferrer Á, Picola-Brau N, Martínez-Breijo S, Costa-Planells M, López-Abad A, García-Puche M, Jiménez Marrero P, Martínez Corral R.
PMID: 42551521 [PubMed - as supplied by publisher]


Artificial intelligence in prostate cancer diagnosis and management: state-of-the-art approaches and emerging innovations.
Clin Adv Hematol Oncol
Lee MS, Shi CT, Kim TH, Morales Martinez GA, Vasdev R, Waddle M, Takahashi N, Boorjian SA, Khanna A.
PMID: 42550814 [PubMed - indexed for MEDLINE]


Deep learning-based prostate cancer diagnosis on MRI with hip prostheses: artifact and sequence effects.
Abdom Radiol (NY)
Nakai H, Kurata Y, Takahashi H, Adamo D, Froemming A, LeGout J, Kawashima A, Cai J, Kido A, Kuanar S, Gloe J, Borisch E, Riederer S, Khanna A, Takahashi N.
PMID: 42550188 [PubMed - as supplied by publisher]


Concordance Between Institutional and Central Pathology, Surgery, and Radiology Reviews on the Children's Oncology Group AREN03B2 Renal Tumor Biology and Classification Study.
Pediatr Blood Cancer
Mullen EA, Renfro LA, Ehrlich PF, Khanna G, Gratias EJ, Cost NG, Parsons LN, Grundy PE, Fernandez CV, Geller JI, Dome JS, AREN03B2 study committee.
PMID: 42549996 [PubMed - as supplied by publisher]


Cardiovascular-Kidney-Metabolic Syndrome Severity and Risk of Pancreatic Cancer in a Large Prospective Cohort.
Diabetes Metab Res Rev
Choi M, Heo SJ, Kwon YJ, Kang CM.
PMID: 42549759 [PubMed - indexed for MEDLINE]


Clinical-imaging fusion model for risk assessment of clinically significant prostate cancer.
Front Oncol
Chen Y, Yu Z, Xu J, Kang X, Liang L, He J, Li Y, Hu Q, Feng B, Liu P.
PMID: 42548646 [PubMed]


Feasibility of opportunistic bone health assessment using low-dose CT trabecular attenuation and (18)F-NaF uptake from PET/CT in prostate cancer.
Front Endocrinol (Lausanne)
Liu C, Liang F, Li Z, Wang Z, Fu W, Mu X.
PMID: 42548567 [PubMed - indexed for MEDLINE]


Prognostic stratification in a diabetic kidney disease trial using plasma concentrations of soluble tumor necrosis factor receptor 1.
Kidney Res Clin Pract
Petrovic V, Malkov VA, Billin AN, Patel UD, Pergola PE, Chertow GM, Skupien J, Krolewski AS.
PMID: 42548168 [PubMed - as supplied by publisher]


Early Physiologic Deobstruction After 980-nm Diode-Laser Contact Prostate Vaporization: Analysis of Evaluable Paired Pressure-Flow Studies From a Consecutive Cohort.
Low Urin Tract Symptoms
Kurano Y, Shimizu N, Ide Y, Togo M, Yoshimura R, Shigehisa R, Yamamoto S, Fukuhara H, Fukata S, Saito M, Inoue K.
PMID: 42548029 [PubMed - indexed for MEDLINE]


   
   Articles 1 - 20 / 190246    Page 1 of 9513  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1